Erika Newman

172 statements · 10 topics · summaries given as host listed separately

Adrenal Tumors · guest expert Colorectal / ARM & Hirschsprung · guest expert Neuroblastoma · guest expert Soft Tissue Sarcoma (lymph nodes) · guest expert Wilms Tumor · guest expert

Featured statements

▶ Ep 2 · 11:50
the families that have been scrutinized or um at least uh. Um, queried the most about whether this was non-accidenal versus accidental trauma, um, leading to a subdural head bleed was, um, people of more ethnic minorities
quote · Hypertension
▶ Ep 2 · 9:58
Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly
guideline · Adrenal Tumors
▶ Ep 1 · 26:03
PET scan is not part of routine initial diagnostic workup but may be used for MIBG-negative soft tissue areas to distinguish recurrence from scar
guideline · Neuroblastoma
▶ Ep 1 · 11:37
First-year surveillance protocol: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spaced out to one year
guideline · Neuroblastoma
▶ Ep 3 · 21:05
Initial workup for abdominal mass includes ultrasound to determine solid vs cystic, then CT with PO and IV contrast if solid
guideline · Neuroblastoma
▶ Ep 3 · 17:58
Once respiratory compromise begins, treatment options include chemotherapy, radiation, or emergent decompressive laparotomy
guideline · Neuroblastoma

Nothing matches these filters — clear the search or widen the filters.

Erika's statements about Adrenal Tumors 14 statements

Open the Adrenal Tumors collection →

Neuroblastoma

▶ Ep 2 · 2:32
quote I mostly am quite reassuring at this stage. It's still a bit early. ↗
▶ Ep 2 · 2:47
quote I think it's important to reassure and help the mom understand that the priority during the pregnancy is the mom. And once the baby is born, then we'll learn more. ↗
▶ Ep 2 · 9:58
guideline Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly ↗
▶ Ep 2 · 13:20
guideline Criteria for surgery in observed neonatal neuroblastoma: >50% volume increase or >50% increase in VMA or HVA ↗
▶ Ep 2 · 14:50
clinical Stage MS (formerly 4S) neuroblastoma with liver and skin metastases in neonates has good biology and can be observed unless respiratory compromise develops from hepatomegaly ↗
▶ Ep 2 · 15:42
clinical Treatment options for MS neuroblastoma with respiratory compromise include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 2 · 26:56
epidemiological Approximately 50% of children's hospitals now use percutaneous biopsy for suspected neuroblastoma ↗
▶ Ep 2 · 28:04
clinical Percutaneous biopsy is equivalent to open biopsy for diagnosis and NMEC determination but may fail for 11q loss of heterozygosity assessment ↗
▶ Ep 2 · 28:55
clinical Optimized percutaneous biopsy technique requires 10-12 cores, higher gauge needle, and pathologist present for frozen section to confirm viable tumor ↗
▶ Ep 2 · 29:45
clinical Open biopsy patients have higher risk of blood transfusion, higher narcotic use, and more frequent hospital admission compared to percutaneous biopsy ↗
▶ Ep 2 · 33:49
clinical Loss of heterozygosity at 11q is the most common segmental chromosomal alteration in neuroblastoma and can elevate risk category ↗
▶ Ep 2 · 37:20
clinical High-risk neuroblastoma patients require double-lumen external catheter (not port) for bone marrow transplant ↗
▶ Ep 2 · 42:40
clinical After 5-6 cycles of chemotherapy, neuroblastomas become more fibrotic and harder to resect ↗
▶ Ep 2 · 52:19
quote One thing we try to teach the residents is that with neuroblastoma surgery, there's no reason to cause disability. ↗
Erika's statements about Colorectal / ARM & Hirschsprung 21 statements

Open the Colorectal / ARM & Hirschsprung collection →

Neuroblastoma

▶ Ep 74 · 2:32
quote I mostly am quite reassuring at this stage. It's still a bit early. ↗
▶ Ep 74 · 2:47
quote I think it's important to reassure and help the mom understand that the priority during the pregnancy is the mom. And once the baby is born, then we'll learn more. ↗
▶ Ep 74 · 9:58
guideline Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly ↗
▶ Ep 74 · 13:20
guideline Criteria for surgery in observed neonatal neuroblastoma: >50% volume increase or >50% increase in VMA or HVA ↗
▶ Ep 74 · 14:50
clinical Stage MS (formerly 4S) neuroblastoma with liver and skin metastases in neonates has good biology and can be observed unless respiratory compromise develops from hepatomegaly ↗
▶ Ep 74 · 15:42
clinical Treatment options for MS neuroblastoma with respiratory compromise include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 74 · 26:56
epidemiological Approximately 50% of children's hospitals now use percutaneous biopsy for suspected neuroblastoma ↗
▶ Ep 74 · 28:04
clinical Percutaneous biopsy is equivalent to open biopsy for diagnosis and NMEC determination but may fail for 11q loss of heterozygosity assessment ↗
▶ Ep 74 · 28:55
clinical Optimized percutaneous biopsy technique requires 10-12 cores, higher gauge needle, and pathologist present for frozen section to confirm viable tumor ↗
▶ Ep 74 · 29:45
clinical Open biopsy patients have higher risk of blood transfusion, higher narcotic use, and more frequent hospital admission compared to percutaneous biopsy ↗
▶ Ep 74 · 33:49
clinical Loss of heterozygosity at 11q is the most common segmental chromosomal alteration in neuroblastoma and can elevate risk category ↗
▶ Ep 74 · 37:20
clinical High-risk neuroblastoma patients require double-lumen external catheter (not port) for bone marrow transplant ↗
▶ Ep 74 · 42:40
clinical After 5-6 cycles of chemotherapy, neuroblastomas become more fibrotic and harder to resect ↗
▶ Ep 74 · 52:19
quote One thing we try to teach the residents is that with neuroblastoma surgery, there's no reason to cause disability. ↗

Colorectal Quiz Episode 37: The Yancey-Soave story of the original surgical descriptions for Hirschsprung disease

▶ Ep 136 · 1:35
quote I never learned about Dr. Yancey when I was training in general surgery and when I was doing my fellowship in pediatric surgery. ↗
▶ Ep 136 · 7:05
epidemiological In 1951-1952, Black academics could not publish their work in mainstream surgical journals. ↗
▶ Ep 136 · 7:05
quote I think that this is an example of sort of some of the historical structural inequities that we know exist, where in 1951 and 1952, you know, Black academics could not publish their work in mainstream journals. ↗
▶ Ep 136 · 12:26
quote I basically just bombarded the meeting because I don't even think you guys had invited me. I think I just came in and asked for five minutes or 10 minutes on the agenda. ↗
▶ Ep 136 · 12:26
clinical The Hirschsprung interest group members write papers, review manuscripts for journals, write board questions, and influence CPT coding. ↗
▶ Ep 136 · 14:30
clinical When reviewing articles for journals, Dr. Newman now sends back revisions to ensure correct references to Dr. Yancey's work are included. ↗
▶ Ep 136 · 14:51
quote When I review a article for a journal, I send back revisions, including, you know, making sure to use the correct references. ↗
Erika's statements about Fecal Incontinence 7 statements

Open the Fecal Incontinence collection →

Colorectal Quiz Episode 37: The Yancey-Soave story of the original surgical descriptions for Hirschsprung disease

▶ Ep 8 · 1:35
quote I never learned about Dr. Yancey when I was training in general surgery and when I was doing my fellowship in pediatric surgery. ↗
▶ Ep 8 · 7:05
quote I think that this is an example of sort of some of the historical structural inequities that we know exist, where in 1951 and 1952, you know, Black academics could not publish their work in mainstream journals. ↗
▶ Ep 8 · 7:05
epidemiological In 1951-1952, Black academics could not publish their work in mainstream surgical journals. ↗
▶ Ep 8 · 12:26
quote I basically just bombarded the meeting because I don't even think you guys had invited me. I think I just came in and asked for five minutes or 10 minutes on the agenda. ↗
▶ Ep 8 · 12:26
clinical The Hirschsprung interest group members write papers, review manuscripts for journals, write board questions, and influence CPT coding. ↗
▶ Ep 8 · 14:30
clinical When reviewing articles for journals, Dr. Newman now sends back revisions to ensure correct references to Dr. Yancey's work are included. ↗
▶ Ep 8 · 14:51
quote When I review a article for a journal, I send back revisions, including, you know, making sure to use the correct references. ↗
Erika's statements about Hirschsprung disease 7 statements

Open the Hirschsprung disease collection →

Colorectal Quiz Episode 37: The Yancey-Soave story of the original surgical descriptions for Hirschsprung disease

▶ Ep 56 · 1:35
quote I never learned about Dr. Yancey when I was training in general surgery and when I was doing my fellowship in pediatric surgery. ↗
▶ Ep 56 · 7:05
epidemiological In 1951-1952, Black academics could not publish their work in mainstream surgical journals. ↗
▶ Ep 56 · 7:05
quote I think that this is an example of sort of some of the historical structural inequities that we know exist, where in 1951 and 1952, you know, Black academics could not publish their work in mainstream journals. ↗
▶ Ep 56 · 12:26
quote I basically just bombarded the meeting because I don't even think you guys had invited me. I think I just came in and asked for five minutes or 10 minutes on the agenda. ↗
▶ Ep 56 · 12:26
clinical The Hirschsprung interest group members write papers, review manuscripts for journals, write board questions, and influence CPT coding. ↗
▶ Ep 56 · 14:30
clinical When reviewing articles for journals, Dr. Newman now sends back revisions to ensure correct references to Dr. Yancey's work are included. ↗
▶ Ep 56 · 14:51
quote When I review a article for a journal, I send back revisions, including, you know, making sure to use the correct references. ↗
Erika's statements about Hypertension 5 statements

Open the Hypertension collection →

Social Determinants of Health

▶ Ep 2 · 10:40
quote how many times has there been a black family that has been Put through child protective services has been called, they need to go to the house, they then, they need to make sure that there's a bunk bed in the house that the kid fell out, um, we keep the child there, you know, after we've deemed them medically fit for discharge, waiting on disposition from the social worker ↗
▶ Ep 2 · 11:25
quote how many times has that happened to a black family whereas, you know, an, an, a majority family or a white family has come with the same story and It's very noticeable that those families are not put through the same scrutiny ↗
▶ Ep 2 · 11:50
quote the families that have been scrutinized or um at least uh. Um, queried the most about whether this was non-accidenal versus accidental trauma, um, leading to a subdural head bleed was, um, people of more ethnic minorities ↗
▶ Ep 2 · 12:40
clinical Bias affects medical decision-making including who gets referred for procedures and who gets surgery ↗
▶ Ep 2 · 13:05
quote I think it's our responsibility to do that, particularly with data arising now that healthy children are dying, um, based on the color of their skin ↗
Erika's statements about Neuroblastoma 30 statements

Open the Neuroblastoma collection →

Neuroblastoma

▶ Ep 1 · 10:02
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 1 · 11:07
epidemiological Nocktern study showed approximately 98% event-free survival and 100% overall survival in observed prenatal neuroblastoma ↗
▶ Ep 1 · 11:37
guideline First-year surveillance protocol: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spaced out to one year ↗
▶ Ep 1 · 11:37
guideline After one year, surveillance becomes every six months, then yearly ↗
▶ Ep 1 · 13:38
quote I will say the last one of these that I had at the 12-month scan it got bigger. And we took it out and it was a ended up being a sequestration. ↗
▶ Ep 1 · 16:07
guideline Laparoscopic approach is reasonable for masses less than 6 centimeters ↗
▶ Ep 1 · 17:00
clinical Biology of neuroblastoma is more important than lymph node status for treatment decisions ↗
▶ Ep 1 · 17:30
clinical Stage MS (formerly 4S) with skin lesions and liver mets still tends to have good biology ↗
▶ Ep 1 · 17:30
quote The biology of these tumors tend to still be good. These aren't bad neuroblastomas. ↗
▶ Ep 1 · 17:58
quote If they're not in any distress, they're treated with my favorite protocol, which is aggressive observation. ↗
▶ Ep 1 · 17:58
guideline Stage MS without distress can be treated with aggressive observation ↗
▶ Ep 1 · 17:58
guideline Once respiratory compromise begins, treatment options include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 1 · 19:52
clinical Liver biopsy in newborns is difficult because bleeding is hard to control ↗
▶ Ep 1 · 21:05
guideline Initial workup for abdominal mass includes ultrasound to determine solid vs cystic, then CT with PO and IV contrast if solid ↗
▶ Ep 1 · 21:05
clinical VIP secretion can cause severe diarrhea in neuroblastoma ↗
▶ Ep 1 · 26:03
guideline PET scan is not part of routine initial diagnostic workup but may be used for MIBG-negative soft tissue areas to distinguish recurrence from scar ↗

Neuroblastoma

▶ Ep 3 · 2:32
quote I mostly am quite reassuring at this stage. It's still a bit early. ↗
▶ Ep 3 · 2:47
quote I think it's important to reassure and help the mom understand that the priority during the pregnancy is the mom. And once the baby is born, then we'll learn more. ↗
▶ Ep 3 · 9:58
guideline Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly ↗
▶ Ep 3 · 13:20
guideline Criteria for surgery in observed neonatal neuroblastoma: >50% volume increase or >50% increase in VMA or HVA ↗
▶ Ep 3 · 14:50
clinical Stage MS (formerly 4S) neuroblastoma with liver and skin metastases in neonates has good biology and can be observed unless respiratory compromise develops from hepatomegaly ↗
▶ Ep 3 · 15:42
clinical Treatment options for MS neuroblastoma with respiratory compromise include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 3 · 26:56
epidemiological Approximately 50% of children's hospitals now use percutaneous biopsy for suspected neuroblastoma ↗
▶ Ep 3 · 28:04
clinical Percutaneous biopsy is equivalent to open biopsy for diagnosis and NMEC determination but may fail for 11q loss of heterozygosity assessment ↗
▶ Ep 3 · 28:55
clinical Optimized percutaneous biopsy technique requires 10-12 cores, higher gauge needle, and pathologist present for frozen section to confirm viable tumor ↗
▶ Ep 3 · 29:45
clinical Open biopsy patients have higher risk of blood transfusion, higher narcotic use, and more frequent hospital admission compared to percutaneous biopsy ↗
▶ Ep 3 · 33:49
clinical Loss of heterozygosity at 11q is the most common segmental chromosomal alteration in neuroblastoma and can elevate risk category ↗
▶ Ep 3 · 37:20
clinical High-risk neuroblastoma patients require double-lumen external catheter (not port) for bone marrow transplant ↗
▶ Ep 3 · 42:40
clinical After 5-6 cycles of chemotherapy, neuroblastomas become more fibrotic and harder to resect ↗
▶ Ep 3 · 52:19
quote One thing we try to teach the residents is that with neuroblastoma surgery, there's no reason to cause disability. ↗
Erika's statements about Neuroblastoma 30 statements

Open the Neuroblastoma collection →

Neuroblastoma

▶ Ep 3 · 10:02
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 3 · 11:07
epidemiological Nocktern study showed approximately 98% event-free survival and 100% overall survival in observed prenatal neuroblastoma ↗
▶ Ep 3 · 11:37
guideline First-year surveillance protocol: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spaced out to one year ↗
▶ Ep 3 · 11:37
guideline After one year, surveillance becomes every six months, then yearly ↗
▶ Ep 3 · 13:38
quote I will say the last one of these that I had at the 12-month scan it got bigger. And we took it out and it was a ended up being a sequestration. ↗
▶ Ep 3 · 16:07
guideline Laparoscopic approach is reasonable for masses less than 6 centimeters ↗
▶ Ep 3 · 17:00
clinical Biology of neuroblastoma is more important than lymph node status for treatment decisions ↗
▶ Ep 3 · 17:30
clinical Stage MS (formerly 4S) with skin lesions and liver mets still tends to have good biology ↗
▶ Ep 3 · 17:30
quote The biology of these tumors tend to still be good. These aren't bad neuroblastomas. ↗
▶ Ep 3 · 17:58
quote If they're not in any distress, they're treated with my favorite protocol, which is aggressive observation. ↗
▶ Ep 3 · 17:58
guideline Once respiratory compromise begins, treatment options include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 3 · 17:58
guideline Stage MS without distress can be treated with aggressive observation ↗
▶ Ep 3 · 19:52
clinical Liver biopsy in newborns is difficult because bleeding is hard to control ↗
▶ Ep 3 · 21:05
clinical VIP secretion can cause severe diarrhea in neuroblastoma ↗
▶ Ep 3 · 21:05
guideline Initial workup for abdominal mass includes ultrasound to determine solid vs cystic, then CT with PO and IV contrast if solid ↗
▶ Ep 3 · 26:03
guideline PET scan is not part of routine initial diagnostic workup but may be used for MIBG-negative soft tissue areas to distinguish recurrence from scar ↗

Neuroblastoma

▶ Ep 6 · 2:32
quote I mostly am quite reassuring at this stage. It's still a bit early. ↗
▶ Ep 6 · 2:47
quote I think it's important to reassure and help the mom understand that the priority during the pregnancy is the mom. And once the baby is born, then we'll learn more. ↗
▶ Ep 6 · 9:58
guideline Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly ↗
▶ Ep 6 · 13:20
guideline Criteria for surgery in observed neonatal neuroblastoma: >50% volume increase or >50% increase in VMA or HVA ↗
▶ Ep 6 · 14:50
clinical Stage MS (formerly 4S) neuroblastoma with liver and skin metastases in neonates has good biology and can be observed unless respiratory compromise develops from hepatomegaly ↗
▶ Ep 6 · 15:42
clinical Treatment options for MS neuroblastoma with respiratory compromise include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 6 · 26:56
epidemiological Approximately 50% of children's hospitals now use percutaneous biopsy for suspected neuroblastoma ↗
▶ Ep 6 · 28:04
clinical Percutaneous biopsy is equivalent to open biopsy for diagnosis and NMEC determination but may fail for 11q loss of heterozygosity assessment ↗
▶ Ep 6 · 28:55
clinical Optimized percutaneous biopsy technique requires 10-12 cores, higher gauge needle, and pathologist present for frozen section to confirm viable tumor ↗
▶ Ep 6 · 29:45
clinical Open biopsy patients have higher risk of blood transfusion, higher narcotic use, and more frequent hospital admission compared to percutaneous biopsy ↗
▶ Ep 6 · 33:49
clinical Loss of heterozygosity at 11q is the most common segmental chromosomal alteration in neuroblastoma and can elevate risk category ↗
▶ Ep 6 · 37:20
clinical High-risk neuroblastoma patients require double-lumen external catheter (not port) for bone marrow transplant ↗
▶ Ep 6 · 42:40
clinical After 5-6 cycles of chemotherapy, neuroblastomas become more fibrotic and harder to resect ↗
▶ Ep 6 · 52:19
quote One thing we try to teach the residents is that with neuroblastoma surgery, there's no reason to cause disability. ↗
Erika's statements about Pediatric Oncology 30 statements

Open the Pediatric Oncology collection →

Neuroblastoma

▶ Ep 184 · 10:02
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 184 · 11:07
epidemiological Nocktern study showed approximately 98% event-free survival and 100% overall survival in observed prenatal neuroblastoma ↗
▶ Ep 184 · 11:37
guideline After one year, surveillance becomes every six months, then yearly ↗
▶ Ep 184 · 11:37
guideline First-year surveillance protocol: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spaced out to one year ↗
▶ Ep 184 · 13:38
quote I will say the last one of these that I had at the 12-month scan it got bigger. And we took it out and it was a ended up being a sequestration. ↗
▶ Ep 184 · 16:07
guideline Laparoscopic approach is reasonable for masses less than 6 centimeters ↗
▶ Ep 184 · 17:00
clinical Biology of neuroblastoma is more important than lymph node status for treatment decisions ↗
▶ Ep 184 · 17:30
quote The biology of these tumors tend to still be good. These aren't bad neuroblastomas. ↗
▶ Ep 184 · 17:30
clinical Stage MS (formerly 4S) with skin lesions and liver mets still tends to have good biology ↗
▶ Ep 184 · 17:58
guideline Stage MS without distress can be treated with aggressive observation ↗
▶ Ep 184 · 17:58
guideline Once respiratory compromise begins, treatment options include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 184 · 17:58
quote If they're not in any distress, they're treated with my favorite protocol, which is aggressive observation. ↗
▶ Ep 184 · 19:52
clinical Liver biopsy in newborns is difficult because bleeding is hard to control ↗
▶ Ep 184 · 21:05
clinical VIP secretion can cause severe diarrhea in neuroblastoma ↗
▶ Ep 184 · 21:05
guideline Initial workup for abdominal mass includes ultrasound to determine solid vs cystic, then CT with PO and IV contrast if solid ↗
▶ Ep 184 · 26:03
guideline PET scan is not part of routine initial diagnostic workup but may be used for MIBG-negative soft tissue areas to distinguish recurrence from scar ↗

Neuroblastoma

▶ Ep 252 · 2:32
quote I mostly am quite reassuring at this stage. It's still a bit early. ↗
▶ Ep 252 · 2:47
quote I think it's important to reassure and help the mom understand that the priority during the pregnancy is the mom. And once the baby is born, then we'll learn more. ↗
▶ Ep 252 · 9:58
guideline Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly ↗
▶ Ep 252 · 13:20
guideline Criteria for surgery in observed neonatal neuroblastoma: >50% volume increase or >50% increase in VMA or HVA ↗
▶ Ep 252 · 14:50
clinical Stage MS (formerly 4S) neuroblastoma with liver and skin metastases in neonates has good biology and can be observed unless respiratory compromise develops from hepatomegaly ↗
▶ Ep 252 · 15:42
clinical Treatment options for MS neuroblastoma with respiratory compromise include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 252 · 26:56
epidemiological Approximately 50% of children's hospitals now use percutaneous biopsy for suspected neuroblastoma ↗
▶ Ep 252 · 28:04
clinical Percutaneous biopsy is equivalent to open biopsy for diagnosis and NMEC determination but may fail for 11q loss of heterozygosity assessment ↗
▶ Ep 252 · 28:55
clinical Optimized percutaneous biopsy technique requires 10-12 cores, higher gauge needle, and pathologist present for frozen section to confirm viable tumor ↗
▶ Ep 252 · 29:45
clinical Open biopsy patients have higher risk of blood transfusion, higher narcotic use, and more frequent hospital admission compared to percutaneous biopsy ↗
▶ Ep 252 · 33:49
clinical Loss of heterozygosity at 11q is the most common segmental chromosomal alteration in neuroblastoma and can elevate risk category ↗
▶ Ep 252 · 37:20
clinical High-risk neuroblastoma patients require double-lumen external catheter (not port) for bone marrow transplant ↗
▶ Ep 252 · 42:40
clinical After 5-6 cycles of chemotherapy, neuroblastomas become more fibrotic and harder to resect ↗
▶ Ep 252 · 52:19
quote One thing we try to teach the residents is that with neuroblastoma surgery, there's no reason to cause disability. ↗
Erika's statements about Soft Tissue Sarcoma (lymph nodes) 14 statements

Open the Soft Tissue Sarcoma (lymph nodes) collection →

Neuroblastoma

▶ Ep 5 · 2:32
quote I mostly am quite reassuring at this stage. It's still a bit early. ↗
▶ Ep 5 · 2:47
quote I think it's important to reassure and help the mom understand that the priority during the pregnancy is the mom. And once the baby is born, then we'll learn more. ↗
▶ Ep 5 · 9:58
guideline Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly ↗
▶ Ep 5 · 13:20
guideline Criteria for surgery in observed neonatal neuroblastoma: >50% volume increase or >50% increase in VMA or HVA ↗
▶ Ep 5 · 14:50
clinical Stage MS (formerly 4S) neuroblastoma with liver and skin metastases in neonates has good biology and can be observed unless respiratory compromise develops from hepatomegaly ↗
▶ Ep 5 · 15:42
clinical Treatment options for MS neuroblastoma with respiratory compromise include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 5 · 26:56
epidemiological Approximately 50% of children's hospitals now use percutaneous biopsy for suspected neuroblastoma ↗
▶ Ep 5 · 28:04
clinical Percutaneous biopsy is equivalent to open biopsy for diagnosis and NMEC determination but may fail for 11q loss of heterozygosity assessment ↗
▶ Ep 5 · 28:55
clinical Optimized percutaneous biopsy technique requires 10-12 cores, higher gauge needle, and pathologist present for frozen section to confirm viable tumor ↗
▶ Ep 5 · 29:45
clinical Open biopsy patients have higher risk of blood transfusion, higher narcotic use, and more frequent hospital admission compared to percutaneous biopsy ↗
▶ Ep 5 · 33:49
clinical Loss of heterozygosity at 11q is the most common segmental chromosomal alteration in neuroblastoma and can elevate risk category ↗
▶ Ep 5 · 37:20
clinical High-risk neuroblastoma patients require double-lumen external catheter (not port) for bone marrow transplant ↗
▶ Ep 5 · 42:40
clinical After 5-6 cycles of chemotherapy, neuroblastomas become more fibrotic and harder to resect ↗
▶ Ep 5 · 52:19
quote One thing we try to teach the residents is that with neuroblastoma surgery, there's no reason to cause disability. ↗
Erika's statements about Wilms Tumor 14 statements

Open the Wilms Tumor collection →

Neuroblastoma

▶ Ep 9 · 2:32
quote I mostly am quite reassuring at this stage. It's still a bit early. ↗
▶ Ep 9 · 2:47
quote I think it's important to reassure and help the mom understand that the priority during the pregnancy is the mom. And once the baby is born, then we'll learn more. ↗
▶ Ep 9 · 9:58
guideline Surveillance protocol for observed neonatal masses: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spacing out through first year, then every 6 months, then yearly ↗
▶ Ep 9 · 13:20
guideline Criteria for surgery in observed neonatal neuroblastoma: >50% volume increase or >50% increase in VMA or HVA ↗
▶ Ep 9 · 14:50
clinical Stage MS (formerly 4S) neuroblastoma with liver and skin metastases in neonates has good biology and can be observed unless respiratory compromise develops from hepatomegaly ↗
▶ Ep 9 · 15:42
clinical Treatment options for MS neuroblastoma with respiratory compromise include chemotherapy, radiation, or emergent decompressive laparotomy ↗
▶ Ep 9 · 26:56
epidemiological Approximately 50% of children's hospitals now use percutaneous biopsy for suspected neuroblastoma ↗
▶ Ep 9 · 28:04
clinical Percutaneous biopsy is equivalent to open biopsy for diagnosis and NMEC determination but may fail for 11q loss of heterozygosity assessment ↗
▶ Ep 9 · 28:55
clinical Optimized percutaneous biopsy technique requires 10-12 cores, higher gauge needle, and pathologist present for frozen section to confirm viable tumor ↗
▶ Ep 9 · 29:45
clinical Open biopsy patients have higher risk of blood transfusion, higher narcotic use, and more frequent hospital admission compared to percutaneous biopsy ↗
▶ Ep 9 · 33:49
clinical Loss of heterozygosity at 11q is the most common segmental chromosomal alteration in neuroblastoma and can elevate risk category ↗
▶ Ep 9 · 37:20
clinical High-risk neuroblastoma patients require double-lumen external catheter (not port) for bone marrow transplant ↗
▶ Ep 9 · 42:40
clinical After 5-6 cycles of chemotherapy, neuroblastomas become more fibrotic and harder to resect ↗
▶ Ep 9 · 52:19
quote One thing we try to teach the residents is that with neuroblastoma surgery, there's no reason to cause disability. ↗

Summaries Erika gave as host · 5 summaries

Recaps of other experts' statements, not Erika's own clinical position.

Summaries Erika gave as host · Hypertension 5 summaries

Open the Hypertension collection →

Social Determinants of Health

▶ Ep 2 · 12:10
host summary Erika Newman summarizing the discussion: Data from the Implicit Association Test (IAT) collecting data from millions of participants shows all healthcare providers have bias that favors whites ↗
▶ Ep 2 · 12:25
host summary Erika Newman summarizing the discussion: the data shows that all healthcare providers have bias that, um, favors whites ↗
▶ Ep 2 · 12:55
host summary Erika Newman summarizing the discussion: Children and adolescents experience bias not only in healthcare but in education and the criminal justice system ↗
▶ Ep 2 · 13:05
host summary Erika Newman summarizing the discussion: Biases are not hard-wired, can be changed, and can be replaced with new associations ↗
▶ Ep 2 · 46:51
host summary Erika Newman summarizing the discussion: In Sweden, which has universal healthcare, similar disparities are seen based on neighborhood locations affecting health outcomes ↗